Abel Hall LLC’s Avita Medical RCEL Stock Holding History

Abel Hall LLC’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.2K	Sell	15,779 -1,031	-6%	-$4.45K	0.01%	878
2026 Q1	$62.2K	Buy	+16,810	New	+$70.6K	0.01%	726

Other funds holding RCEL

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Abel Hall LLC's RCEL Position: Q2 2026 in Review

Abel Hall LLC reduced its Avita Medical (RCEL) stake by 6.1% in Q2 2026, selling an estimated $4.45K and leaving 15,779 shares worth $65.2K. The position accounts for 0.01% of the portfolio, ranked #878.

Abel Hall LLC first reported a position in RCEL in Q1 2026 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

Abel Hall LLC held 15,779 shares of Avita Medical worth $65.2K as of Q2 2026.
Abel Hall LLC sold 1,031 Avita Medical shares in Q2 2026, an estimated $4.45K.
Avita Medical made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #878 holding.
Abel Hall LLC first reported a position in Avita Medical in Q1 2026 and has held it in 2 quarters since.
73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.